ABIONYX: Details on Voting Rights and Shares

The biopharmaceutical company ABIONYX, listed on Euronext Paris Compartment C, has released updated figures concerning its voting rights and shares as of October 31, 2026. The outstanding share capital comprises 44,067,714 shares. The total number of voting rights is 56,189,171 gross. This number includes all voting rights, even suspended ones.

In terms of voting rights "exercisable at the General Meeting," this net total amounts to 55,928,966, in accordance with the recommendations of the AMF (French Financial Markets Authority). This information aims to inform the public and investors about the governance structure and the distribution of powers within the company. This is part of a transparency framework essential for compliance with current regulatory obligations.